Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

July 22, 2022

Primary Completion Date

August 12, 2024

Study Completion Date

August 12, 2024

Conditions
Multiple Myeloma
Interventions
DRUG

Belantamab mafodotin

MMRR patients included in Named Patient Program e Expanded Access Program

Trial Locations (10)

Unknown

AOU Ospedali Riuniti Umberto I, Ancona

Policlinico Sant'Orsola Malpighi, Aou Di Bologna, Bologna

A.O. Spedali Civili di Brescia, Brescia

"Ospedale A. Businco", Cagliari

AOU Policlinico Vittorio Emanuele, Catania

A.O.U. Arcispedale Sant'Anna, Ferrara

Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico, Milan

A.O.U. Federico II, Napoli

La Maddalena S.p.a, Palermo

Policlinico Umberto I - Università La Sapienza, Roma

All Listed Sponsors
lead

Fondazione EMN Italy Onlus

OTHER